Header Logo

Connection

Lynn Morris to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Lynn Morris has written about Clinical Trials, Phase II as Topic.
Lynn Morris
Connection Strength
0,055
Clinical Trials, Phase II as Topic
  1. Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. BMJ Open. 2023 08 28; 13(8):e076843.
    View in: PubMed
    Score: 0,055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.